Xiaoming Ye
Impact in
Papers in
-
- Signaling Pathways in Disease 1
- Oncology 6
- Pancreatic and Hepatic Oncology Research 4
- Cancer Treatment and Pharmacology 1
- Co-authors
- Ke‐Wu Zeng (3 shared papers)Kaiyuan Ni (4 shared papers)Yanming Chen (1 shared paper)Suhua Li (1 shared paper)Shuo Lin (1 shared paper)Panwei Mu (1 shared paper)Manman Wang (1 shared paper)Xixiang Tang (1 shared paper)
- Journals
- Acta Pharmaceutica Sinica B (1 paper)Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (1 paper)RSC Advances (1 paper)BMC Nursing (1 paper)Journal of Surgical Research (1 paper)
- Partner nations
- ChinaSpainNew Zealand
In The Last Decade
Xiaoming Ye
23 papers receiving 371 citations
Peers
Comparison fields: 5 of 88
- Research and Theory 8
- Leadership and Management 5
- Endocrinology, Diabetes and Metabolism 58
- Biological Psychiatry 7
- Neurology 19
Countries citing papers authored by Xiaoming Ye
This map shows the geographic impact of Xiaoming Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoming Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoming Ye more than expected).
Fields of papers citing papers by Xiaoming Ye
This network shows the impact of papers produced by Xiaoming Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoming Ye. The network helps show where Xiaoming Ye may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoming Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 66 | |
| 2 | 2016 | 65 | |
| 3 | 2013 | 42 | |
| 4 | 2022 | 33 | |
| 5 | 2015 | 27 | |
| 6 | 2024 | 23 | |
| 7 | 2000 | 13 | |
| 8 | 2005 | 13 | |
| 9 | 2021 | 13 | |
| 10 | 2006 | 13 | |
| 11 | 2015 | 12 | |
| 12 | 2006 | 11 | |
| 13 | 2013 | 10 | |
| 14 | 2015 | 7 | |
| 15 | Mammalian target of rapamycin as a novel target in the treatment of hepatocellular carcinoma. | 2011 | 7 |
| 16 | 2015 | 4 | |
| 17 | 2018 | 4 | |
| 18 | 2022 | 3 | |
| 19 | 2014 | 2 | |
| 20 | 2025 | 2 |
About Xiaoming Ye
Xiaoming Ye is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Epidemiology and Surgery, having authored 25 papers that have together received 373 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (4 papers), Gallbladder and Bile Duct Disorders (3 papers), Autophagy in Disease and Therapy (2 papers), Alcohol Consumption and Health Effects (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Signaling Pathways in Disease (1 paper), Diabetes Management and Research (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Research and Theory (8 citations), Leadership and Management (5 citations), Endocrinology, Diabetes and Metabolism (58 citations), Biological Psychiatry (7 citations) and Neurology (19 citations). Xiaoming Ye has collaborated with scholars based in China, Spain and New Zealand. Frequent co-authors include Ke‐Wu Zeng, Kaiyuan Ni, Yanming Chen, Suhua Li, Shuo Lin, Panwei Mu, Manman Wang, Xixiang Tang, Xiaoxian Qian and Qiang Guo. Their work appears in journals such as Acta Pharmaceutica Sinica B, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, RSC Advances, BMC Nursing and Journal of Surgical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.